ID   EP [Human breast carcinoma]
AC   CVCL_WS82
DR   Wikidata; Q93540959
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=1961733;
RX   PubMed=3971380;
CC   Doubling time: 27 hours (PubMed=3971380).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RA   Leibovitz A.;
RT   "Cell lines from human breast.";
RL   (In book chapter) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.161-184; Academic Press; New York; USA (1994).
//
RX   PubMed=1961733; DOI=10.1073/pnas.88.23.10657; PMCID=PMC52989;
RA   Runnebaum I.B., Nagarajan M., Bowman M., Soto D., Sukumar S.;
RT   "Mutations in p53 as potential molecular markers for human breast
RT   cancer.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:10657-10661(1991).
//
RX   PubMed=3971380;
RA   Chu M.Y., Hagerty M.G., Wiemann M.C., Tibbetts L.M., Sato S.,
RA   Cummings F.J., Bogaars H.A., Leduc E.H., Calabresi P.;
RT   "Differential characteristics of two newly established human breast
RT   carcinoma cell lines.";
RL   Cancer Res. 45:1357-1366(1985).
//